When it comes to weight loss, slowly and surely is the way to go – making lifestyle changes rather than going on extreme ...

Around 1.5 million people in the UK are thought to be using weight loss jabs, with many paying privately as NHS supplies ...

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Weight loss jabs will be given to 3,000 people in a trial to explore whether they can get people back into work, The i Paper ...

Late-night snacks can support weight loss—what matters most is choosing balanced, nutrient-dense options. A top pick is ...

Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their ...

Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its experimental weight-loss drug candidate next ...